Net Cash Provided by (Used in) Financing Activities in USD of Medicus Pharma Ltd. from 2023 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Medicus Pharma Ltd. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2023 to Q1 2025.
  • Medicus Pharma Ltd. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $3.76M.
  • Medicus Pharma Ltd. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $12.7M, a 126% increase from 2023.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Medicus Pharma Ltd. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $3.76M +$3.76M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q1 2024 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12

Medicus Pharma Ltd. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $12.7M +$7.08M +126% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $5.61M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.